Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-04-13

Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and the Tolerance of an Omega 3 Fatty Acids Supplementation in ADHD Children [Phase 4]

View source ↗

Summary

This entry notes a Phase 4 clinical trial evaluating the efficacy and tolerability of omega-3 fatty acid supplementation in children with Attention Deficit Hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids supplement (Omega-3 fatty acids)

Snippet

Sponsor: Laboratoires URGO | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: UNKNOWN